How antioxidants can accelerate cancers, and why they don’t protect against them — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/07/140710094434.htm
source : http://www.sciencedaily.com/releases/2014/07/140710094434.htm
source : http://www.sciencedaily.com/releases/2014/05/140515173505.htm
source : http://www.sciencedaily.com/releases/2014/03/140317203754.htm
source : http://www.sciencedaily.com/releases/2014/03/140310111543.htm
source : http://www.sciencedaily.com/releases/2014/02/140228121437.htm
source : http://www.sciencedaily.com/releases/2014/02/140225101644.htm
source : http://www.sciencedaily.com/releases/2014/02/140213141958.htm
The research, which is published today in the New England Journal of Medicine, indicates Vemurafenib, a BRAF inhibitor that has been approved as a treatment for advanced melanomas, is also successful in treating Leukemia. …
Peter Sasieni and colleagues, from Queen Mary University of London, UK, examined the link between screening women aged 50 to 64 for cervical cancer and cervical cancer diagnosed at ages 65 to 83. Their study included all 65 to 83-year old women in England and Wales diagnosed with cervical cancer between 2007 and 2012, a total of 1,341 women. …
But early transplantation does appear to be beneficial among a small group of patients who are at the very highest risk, the study found. Lead author is Patrick Stiff, MD, director of Loyola University Medical Center’s Cardinal Bernardin Cancer Center. The study was developed by the SWOG cancer research cooperative group and funded by the National Cancer Institute. Stiff is chair of the SWOG Bone Marrow and Stem Cell Transplantation Committee. …